NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NASDAQ: EDSA 47.03%
$38M Defense Backlog vs. $6M Market Cap, Breakthrough Biotech Data, and the Quantum Security Land Grab
NASDAQ: CDIO 32.65%
BioMedNewsBreaks - Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Schedules Investor Conference Call for Feb. 19, 2026
OTC: DBLVF 24.07%
Top 5 Canadian Mining Stocks This Week: Adex Mining Shines with 171 Percent Gain
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
OTC: NGNE 77.39%
OTC: KORE 77.39%
OTC: EDSA 77.39%
OTC: CDIO 77.39%
OTC: DBLVF 77.39%
